Bridger Management, LLC Uni Qure N.V. Transaction History

Bridger Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.82 - $6.93 $1.75 Million - $2.51 Million	362,349 New	362,349 $1.88 Million
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $1.97 Million - $2.9 Million	350,340 Added 2917.31%	362,349 $2.45 Million
Q3 2023 Nov 14, 2023	SELL	$6.71 - $11.83 $664,229 - $1.17 Million	-98,991 Reduced 89.18%	12,009 $80,000
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $1.23 Million - $2.46 Million	111,000 New	111,000 $1.27 Million

153

41M

925K

617K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $270M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Bridger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridger Management, LLC with notifications on news.